Combining Glucagon-Like Peptide-1 Receptor agonists and Sodium-Glucose Cotransporter-2 Inhibitors in the management of Type 2 Diabetes Mellitus: A protocol for a scoping review / Carlos Esteban Builes Montaño ; Suarez Rodriguez, Andres F. ; Carreño, Johanna  

Público ISBD Título : Combining Glucagon-Like Peptide-1 Receptor agonists and Sodium-Glucose Cotransporter-2 Inhibitors in the management of Type 2 Diabetes Mellitus: A protocol for a scoping review Tipo de documento : documento electrónico Autores : Carlos Esteban Builes Montaño, Autor ; Suarez Rodriguez, Andres F., Autor ; Carreño, Johanna, Autor Fecha de publicación : 2025 Títulos uniformes : F1000Research Idioma : Inglés (eng) Palabras clave : Diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter-2 inhibitors. Resumen : Introduction Diabetes treatment has evolved from solely focusing on glucose control to a more patient-centered approach that includes medications designed to reduce specific risks in addition to managing blood glucose control. Methods and analysis We propose a scoping review to explore the available clinical research on the combined use of GLP-1RAs and SGLT2is. This review will adhere to the guidelines outlined in the Joanna Briggs Institute Reviewer’s Manual and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Mención de responsabilidad : Carlos E. Builes-Montaño https://orcid.org/0000-0002-2418-61592,3, Andres F. Suarez-Rodriguez1, Johanna Carreño1 DOI (Digital Object Identifier) : 10.12688/f1000research.159628.1 Derechos de uso : CC BY-NC-ND En línea : https://f1000research.com/articles/14-202 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis Combining Glucagon-Like Peptide-1 Receptor agonists and Sodium-Glucose Cotransporter-2 Inhibitors in the management of Type 2 Diabetes Mellitus: A protocol for a scoping review [documento electrónico] / Carlos Esteban Builes Montaño, Autor ; Suarez Rodriguez, Andres F., Autor ; Carreño, Johanna, Autor . - 2025. Obra : F1000Research Idioma : Inglés (eng) Palabras clave : Diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter-2 inhibitors. Resumen : Introduction Diabetes treatment has evolved from solely focusing on glucose control to a more patient-centered approach that includes medications designed to reduce specific risks in addition to managing blood glucose control. Methods and analysis We propose a scoping review to explore the available clinical research on the combined use of GLP-1RAs and SGLT2is. This review will adhere to the guidelines outlined in the Joanna Briggs Institute Reviewer’s Manual and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Mención de responsabilidad : Carlos E. Builes-Montaño https://orcid.org/0000-0002-2418-61592,3, Andres F. Suarez-Rodriguez1, Johanna Carreño1 DOI (Digital Object Identifier) : 10.12688/f1000research.159628.1 Derechos de uso : CC BY-NC-ND En línea : https://f1000research.com/articles/14-202 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD002341	AC-2025-024	Archivo digital	Producción Científica	Artículos científicos	Disponible

---

1 (1 - 1 / 1) Por página: 25 50 100 200